Evaluation of the potential inhibition effect of Paritaprevir on UGT 1A1 enzyme activity using human liver microsomes

Alam, Novera.

Abstract: Abstract The treatment landscape of chronic hepatitis C (HCV) has changed substantially over the last decade with the introduction of direct-acting antiviral drugs, creating more options to treat the disease. However, the importance of clinically relevant drug-drug interaction remains a challenge. Paritaprevir has been a successful candidate when used in a multidrug regimen for the treat... read more

Sackler School of Graduate Biomedical Sciences. Department of Pharmacology and Experimental Therapeutics.
Permanent URL
ID: tufts:22743
To Cite: DCA Citation Guide